<DOC>
	<DOCNO>NCT03095053</DOCNO>
	<brief_summary>Introduction Embryo aneuploidy likely leading cause implantation failure IVF cycle . Since inception IVF , non-invasive morphology base score mostly use selection embryo transfer , result relative low embryo implantation rate . Our understanding optimal condition require vitro embryo culture IVF advance significantly past two decade . The implementation improve vitro embryo culture technology ( i.e. , culture medium incubator ) result increase number good quality embryos consequently number blastocyst develop . While blastocyst transfer seemingly improve reproductive outcome IVF , use improve preimplantation genetic screening ( PGS ) technology reveal embryo implantation still sub-optimal . The main objective randomize control trial investigate superiority comprehensive chromosome screening ( CCS ) euploid blastocyst transfer compare morphology score blastocyst transfer , FET . Methods This trial perform single-centre randomized control trial ( RCT ) segmented-IVF program , intracyoplasmic sperm injection ( ICSI ) , blastocyst freeze-all artificial frozen embryo transfer ( art-FET ) . Normo-ovulatory infertile patient , maternal age ≤35 year least two blastocyst morphology grade 2BB cryopresreved , randomize computer generate randomized allocation one CCS morphology group . All transfer single embryo tranfers ( SET ) art-FET , first transfer follow ICSI blastocysts freeze-all include . Consent Ethics Akdeniz University Medical Faculty Clinical Research Ethics Committee approve trial ( reference number : 2015/399 ) , anonymized result release ClinicalTrials.gov . All patient provide informed consent , include agreement use anonymised data research .</brief_summary>
	<brief_title>CCS Versus Blastocyst Morphology Selection</brief_title>
	<detailed_description>Introduction Embryo aneuploidy likely leading cause implantation failure IVF cycle . Since inception IVF , non-invasive morphology base score mostly use selection embryo transfer , result relative low embryo implantation rate . Embryo morphology assessment method significant limitation ( i.e. , assessment subjective method use fix time-point assessment define dynamic embryo development ) shortcoming ( i.e. , expose embryos sub-optimal condition assessment ) . Notwithstanding limitation shortcoming method use world-wide continued , relatively simple non-invasive method score show positively correlated embryo euploidy , ongoing pregnancy , live birth ( Van Royen et al. , 1999 , Ahlstrom et al. , 2011 , Forman et al. , 2013 , Capalbo et al. , 2014 , Oron et al. , 2014 , Rhenman et al. , 2015 ) . However multiple gestation still represent one significant complication IVF , mainly result multiple-embryo embryo transfer , multiple-embryo transfer use overcome relatively low embryo implantation rate IVF . Our understanding optimal condition require vitro embryo culture IVF advance significantly past two decade . The implementation improve vitro embryo culture technology ( i.e. , culture medium incubator ) result increase number good quality embryos consequently number blastocyst develop . While blastocyst transfer seemingly improve reproductive outcome IVF , increase use single embryo transfer ( SET ) use improve preimplantation genetic screening ( PGS ) technology reveal embryo implantation still sub-optimal ( Schoolcraft et al. , 2013 ) . New CCS platforms major breakthrough PGS , allow 24-chromosome screening perform high accuracy single cell ( Harper Harton , 2010 ) . Along evidence morphology score moderately associate euploidy transfer CCS euploid embryos result high implantation rate ( Dahdouh et al. , 2015 ) , continue use morphology base score method increasingly challenge . In addition advance IVF , significant improvement also make cryopreservation technology . These improvement result significant improvement frozen-thawed embryo survival ( i.e . minimize risk ) , post-thaw developmental competence ( Cobo et al. , 2012 ; Balaban et al. , 2008 ) , reproductive outcome FET ( Evans et al. , 2014 ; Ozgur et al. , 2015 ) . The benefit FET include ; transfer embryo physiologic endometrium ( i.e. , early luteal phase ) , capability time transfer accurately , patient specific endometrial preparation use ( Casper Yanushpolsky , 2016 , Franasiak et al. , 2016 ; Groenewoud et al. , 2013 , Yarali et al. , 2016 ) . More RCT require confirm whether CCS select blastocyst transfer truly superior conventional morphology base selection blastocyst , term reproductive outcome . The present study test superiority CCS selection compare FET reproductive outcome blastocyst freeze-all cycle ; avoid complication associate controlled ovarian stimulation ( COS ) use fresh ET . Objectives The main objective RCT investigate superiority reproductive outcome CCS euploid blastocyst FET compare morphology score blastocyst FET . The choice transfer blastocyts FET eliminate confounding relate endometrial development , freeze-all strategy ensure comparison primary blastocyst . The ultimate aim study investigate one two blastocyst selection method efficient term ongoing pregnancy rate . Ongoing pregnancy rate define intrauterine pregnancy fetal-heart beat ultrasound 5-8 gestational week continue pass 14 week . Secondary objectives The secondary objective measurement RCT investigate whether early pregnancy loss also superior CCS euploid blastocyst compare morphology score blastocyst . Keywords : blastocyst ; comprehensive chromosome screening ; euploidy ; frozen embryo transfer</detailed_description>
	<criteria>Patient couple include trial satisfy follow criterion : maternal age ≤35 year ; 3 previous embryo transfer , regular normoovulatory menstrual cycle ; use oocyte , body mass index ( BMI ) 1832 kg/m2 , antral follicle count ( AFC ) ≥ 10 . Patient couple exclude trial follow reason : patient couple wish terminate participation ; patient contraindication drug use , patient pathophysiology unrelated reproduction , oocytes collect oocyte retrieval ; &lt; 2 blastocyst grade 2BB extended vitro embryo culture .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>blastocyst</keyword>
	<keyword>comprehensive chromosome screening</keyword>
	<keyword>euploidy</keyword>
	<keyword>frozen embryo transfer</keyword>
</DOC>